XOM
50
2
AA
35
3
PCAR
52
2
SWN
57
-3
FOX
42
2
WMT
67
4
UAL
56
2
HCA
50
2
FTI
86
2
WBA
28
4
SRCL
40
6
SBUX
27
2
MPC
44
14
TEL
75
4
MHK
55
2
OXY
46
-2
GM
77
2
DHI
54
6
NVDA
63
4
EXPD
45
5
XOM
50
2
AA
35
3
PCAR
52
2
SWN
57
-3
FOX
42
2
WMT
67
4
UAL
56
2
HCA
50
2
FTI
86
2
WBA
28
4
SRCL
40
6
SBUX
27
2
MPC
44
14
TEL
75
4
MHK
55
2
OXY
46
-2
GM
77
2
DHI
54
6
NVDA
63
4
EXPD
45
5
Financhill
Back

Axsome Therapeutics 10K Form

Buy
61

AXSM
Axsome Therapeutics

Last Price:
74.73
Seasonality Move:
3.78%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive AXSM News And Ratings

See the #1 stock for the next 7 days that we like better than AXSM

AXSM Financial Statistics

Sales & Book Value

Annual Sales: $270.6M
Cash Flow: $-30.37M
Price / Cash Flow: 0
Annual Sales: $4.03
Price / Book: 18.56

Profitability

EPS (TTM): -5.20000
Net Income (TTM): $-239.24M
Gross Margin: $244.54M
Return on Equity: -124.52%
Return on Assets: -47.44%

Axsome Therapeutics Earnings Forecast

Key Axsome Therapeutics Financial Ratios

  • The Gross Profit Margin over the past 4 years for AXSM is 90.37%.
  • The Selling, General & Administrative Expenses for AXSM have been equal to 119.41% of Gross Profit Margin.
  • The Research & Development expenses have been 36.20% of Revenue.
  • The Interest Expense is -2.70% of Operating Income.
  • The Net Earning history of AXSM is -88.41% of Total Revenues.
  • Per Share Earnings over the last 11 years have been positive in 2 years.

Axsome Therapeutics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: AXSM
CUSIP: 05464T
Website: axsome.com

Debt

Debt-to-Equity Ratio: 0.93
Current Ratio: 3.63
Quick Ratio: 3.46

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 2536.45

AXSM Technical Analysis vs Fundamental Analysis

Buy
61
Axsome Therapeutics (AXSM) is a Buy

Is Axsome Therapeutics a Buy or a Sell?